Gilead Sciences has broken ground on a new pharmaceutical development and manufacturing hub at its headquarters in Foster City, California245.
The new site is a major element of Gilead's planned $32 billion investment in U.S. manufacturing and R&D through 203035.
This long-term investment is expected to generate $43 billion in economic value for the U.S. and create more than 3,000 direct and indirect jobs by 202835.
The new Foster City facility is positioned as a cornerstone of Gilead's growth and innovation strategy in the U.S.5.
This development follows a shift in Gilead's expansion plans, including consolidating many biologics roles and manufacturing operations in Foster City1.
Sources:
1. https://www.fiercebiotech.com/biotech/gilead-lays-36-people-after-axing-california-expansion-plan
2. https://www.fiercepharma.com/manufacturing/gilead-breaks-ground-foster-city-manufacturing-hub-32b-us-investment-plan-plays-out
3. https://www.gilead.com/company/company-statements/2025/gilead-us-investment-to-create-43-billion-value-to-us-economy
4. https://firstwordpharma.com/story/5994407
5. https://www.gilead.com/news/news-details/2025/gilead-sciences-breaks-ground-on-new-manufacturing-hub-a-cornerstone-of-its-u-s--growth-and-innovation-strategy